Egypt has the world’s highest prevalence of hepatitis C. Gilead has recently finalized an agreement with Egypt, offering the therapy at a price of $900 for a 12 week treatment. That’s a 99% discount! This comes as the company faced criticism concerning the $84,000 price tag it put on the same drug for patients in the United States. Read more here. (Source: FirstWord Pharma, 3/30/14).
You are here: / / Gilead Offers Egypt Discount On New Hepatitis C Drug – A 99% DISCOUNT!